Brenda Furlow

2019

In 2019, Brenda Furlow earned a total compensation of $1.4M as Senior Vice President General Counsel at Bio-Techne, a 18% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$350,574
Option Awards$487,254
Salary$431,400
Stock Awards$162,425
Other$8,250
Total$1,440,173

Furlow received $487.3K in option awards, accounting for 34% of the total pay in 2019.

Furlow also received $350.6K in non-equity incentive plan, $431.4K in salary, $162.4K in stock awards and $8.3K in other compensation.

Rankings

In 2019, Brenda Furlow's compensation ranked 7,509th out of 13,971 executives tracked by ExecPay. In other words, Furlow earned more than 46.3% of executives.

ClassificationRankingPercentile
All
7,509
out of 13,971
46th
Division
Manufacturing
2,909
out of 5,692
49th
Major group
Chemicals And Allied Products
1,093
out of 2,189
50th
Industry group
Drugs
930
out of 1,875
50th
Industry
Biological Products, Except Diagnostic Substances
218
out of 389
44th
Source: SEC filing on September 9, 2019.

Furlow's colleagues

We found four more compensation records of executives who worked with Brenda Furlow at Bio-Techne in 2019.

2019

Charles Kummeth

Bio-Techne

Chief Executive Officer

2019

James Hippel

Bio-Techne

Chief Financial Officer

2019

David Eansor

Bio-Techne

Senior Vice President Biotechnology

2019

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

News

You may also like